-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$3.0068.54% Upside
Biodesix, Inc. Frequently Asked Questions
-
What analysts cover Biodesix, Inc.?
Biodesix, Inc. has been rated by research analysts at Scotiabank, Craig-Hallum in the past 90 days.